portfolio · all active clients

Where everyone is today.

One card per engagement. Sorted by risk so what's burning surfaces first. Click into any card for the full file.

Total active
3
High risk
2
Medium risk
1
Low / none
0

CLIENT-A

Shenzhen MoleQ Diagnostics

high

Class

C

Day

196

Risks

4

Phase 3 — SUBMISSION

56% through the program

next action

2026-05-28Follow up CE Parere Unico decision

BSI Netherlands (NB 2797)

CLIENT-B

Beijing OncoGene Bio

high

Class

D

Day

27

Risks

4

Phase 0 — Evaluation

6% through the program

next action

2026-05-30Deliver IVDR gap analysis report

TBD (shortlisted: TUV SUD, DEKRA)

CLIENT-C

Hangzhou QuickStrip Diagnostics

medium

Class

B

Day

338

Risks

1

Phase 5 — FOLLOW UP

81% through the program

next action

2026-06-30Turin site enrolment review

DEKRA (NB 0344)